“The key issue here is with a maturing portfolio, [I want Trendlines] to be focused on that and help bring those companies to exit,” he explained the strategy change on Nov 21 last year.
Israeli-based investment firm The Trendlines Group is entering 2023 with a different strategy. Instead of scouring the medtech and agrifood sectors for new start-ups to invest in, it is now focused on growing its existing portfolio of “precious” companies to a more mature level and maximising its chances of profitable exits.
Trendlines, listed in Singapore in 2015, has 58 companies in its portfolio. In an interview with The Edge Singapore, Todd Dollinger, one of the two co-chairmen and CEOs of the company, insists on the need to “spend more time with these companies”.
